England Boosts Pharmacy Services for Patients

People in England will gain expanded access to healthcare services at their local pharmacies, as the government announced a significant £340 million deal to boost independent prescribing capabilities. This change, effective this autumn, will empower qualified pharmacists to prescribe medicines directly, reducing the need for patients to see a General Practitioner first.

The initiative builds upon the existing Pharmacy First scheme. Currently, this program allows pharmacists to advise and provide treatments for seven common ailments including sore throats, earaches, sinusitis, shingles, impetigo, infected bites, and urinary tract infections. Five more health conditions will be added to the expanded service, although specific details are yet to be released.

Health minister Stephen Kinnock highlighted that the government is leveraging the expertise of pharmacists to enhance patient access and provide care closer to home. Dr. Amanda Doyle of NHS England emphasized that expanding independent prescribing will optimize the clinical skills within community pharmacy teams, ensuring patients receive appropriate care while alleviating pressure on other NHS services.

Data from the Department of Health and Social Care shows a 43% increase in Pharmacy First consultations between March 2025 and February 2026, with over 3.3 million consultations recorded. Despite this progress, the National Pharmacy Association (NPA) has voiced concerns regarding funding gaps, calling for urgent discussions to address a £2.5 billion identified shortfall and ensure pharmacies can sustain the expanded services.